https://stock.noler.com/us/stock/biocept-inc https://stock.noler.com/us/stock/biocept-inc/accounts-payable https://stock.noler.com/us/stock/biocept-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/biocept-inc/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/biocept-inc/accounts-receivable https://stock.noler.com/us/stock/biocept-inc/accrual-at-carrying-value https://stock.noler.com/us/stock/biocept-inc/accrual-carrying-value-current https://stock.noler.com/us/stock/biocept-inc/accrual-carrying-value-payments https://stock.noler.com/us/stock/biocept-inc/accrued-bonuses-current https://stock.noler.com/us/stock/biocept-inc/accrued-liabilities-current https://stock.noler.com/us/stock/biocept-inc/accrued-rent-current-and-noncurrent https://stock.noler.com/us/stock/biocept-inc/accrued-salaries-current https://stock.noler.com/us/stock/biocept-inc/accrued-sales-commission-current https://stock.noler.com/us/stock/biocept-inc/accrued-vacation-current https://stock.noler.com/us/stock/biocept-inc/accumulated-depreciation https://stock.noler.com/us/stock/biocept-inc/accumulated-depreciation-depletion-and-amortization-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/biocept-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/biocept-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/biocept-inc/additional-paid-in-capital https://stock.noler.com/us/stock/biocept-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/biocept-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/biocept-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/biocept-inc/amended-reports-10-k https://stock.noler.com/us/stock/biocept-inc/amended-reports-10-q https://stock.noler.com/us/stock/biocept-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/biocept-inc/asset-impairment-charges https://stock.noler.com/us/stock/biocept-inc/basic-shares https://stock.noler.com/us/stock/biocept-inc/buybacks-payments-for-repurchase-of-equity https://stock.noler.com/us/stock/biocept-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/biocept-inc/capital-expenditures https://stock.noler.com/us/stock/biocept-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/biocept-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/biocept-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/biocept-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/biocept-inc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biocept-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/biocept-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/biocept-inc/cash https://stock.noler.com/us/stock/biocept-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/biocept-inc/cash-and-equivalents https://stock.noler.com/us/stock/biocept-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/biocept-inc/cash-change https://stock.noler.com/us/stock/biocept-inc/cash-flow-breakdown https://stock.noler.com/us/stock/biocept-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/biocept-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/biocept-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/biocept-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/biocept-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/biocept-inc/clinical-trials https://stock.noler.com/us/stock/biocept-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biocept-inc/common-stock-shares-held-in-employee-trust-shares https://stock.noler.com/us/stock/biocept-inc/common-stock-value https://stock.noler.com/us/stock/biocept-inc/construction-in-progress-gross https://stock.noler.com/us/stock/biocept-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/biocept-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/biocept-inc/convertible-notes-payable https://stock.noler.com/us/stock/biocept-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/biocept-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/biocept-inc/cost-direct-labor https://stock.noler.com/us/stock/biocept-inc/cost-of-revenue https://stock.noler.com/us/stock/biocept-inc/costs-and-expenses https://stock.noler.com/us/stock/biocept-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/biocept-inc/current-assets https://stock.noler.com/us/stock/biocept-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/biocept-inc/current-liabilities https://stock.noler.com/us/stock/biocept-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/biocept-inc/damages-paid-value https://stock.noler.com/us/stock/biocept-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/biocept-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/biocept-inc/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/biocept-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/biocept-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/biocept-inc/debt-convertible-threshold-percentage-of-stock-price-trigger https://stock.noler.com/us/stock/biocept-inc/debt-unamortized-discount https://stock.noler.com/us/stock/biocept-inc/deferred-costs https://stock.noler.com/us/stock/biocept-inc/deferred-costs-current https://stock.noler.com/us/stock/biocept-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/biocept-inc/deferred-offering-costs https://stock.noler.com/us/stock/biocept-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/biocept-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/biocept-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biocept-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/biocept-inc/depreciation https://stock.noler.com/us/stock/biocept-inc/depreciation-and-amortization https://stock.noler.com/us/stock/biocept-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/biocept-inc/derivative-instruments-and-hedges-liabilities https://stock.noler.com/us/stock/biocept-inc/derivative-liabilities-current https://stock.noler.com/us/stock/biocept-inc/diluted-shares https://stock.noler.com/us/stock/biocept-inc/dividends-preferred-stock-stock https://stock.noler.com/us/stock/biocept-inc/due-to-employees-current https://stock.noler.com/us/stock/biocept-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/biocept-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/biocept-inc/eps https://stock.noler.com/us/stock/biocept-inc/eps-basic https://stock.noler.com/us/stock/biocept-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/biocept-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/biocept-inc/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/biocept-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/biocept-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biocept-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/biocept-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/biocept-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-current https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biocept-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/biocept-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/biocept-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/biocept-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/biocept-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/biocept-inc/financial-guarantee-insurance-contracts-premium-receivable-premium-payments-received https://stock.noler.com/us/stock/biocept-inc/financial-guarantee-insurance-contracts-premium-receivable-proceeds-from-premiums-received https://stock.noler.com/us/stock/biocept-inc/financing-cash-flow https://stock.noler.com/us/stock/biocept-inc/form-d-other https://stock.noler.com/us/stock/biocept-inc/form-d-stocks https://stock.noler.com/us/stock/biocept-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/biocept-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/biocept-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/biocept-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/biocept-inc/general-and-administrative-expense https://stock.noler.com/us/stock/biocept-inc/gross-profit https://stock.noler.com/us/stock/biocept-inc/income-tax https://stock.noler.com/us/stock/biocept-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/biocept-inc/income-taxes-paid https://stock.noler.com/us/stock/biocept-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/biocept-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/biocept-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/biocept-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/biocept-inc/insider-transactions-other https://stock.noler.com/us/stock/biocept-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/biocept-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/biocept-inc/insider-transactions-warrants https://stock.noler.com/us/stock/biocept-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/biocept-inc/interest-expense https://stock.noler.com/us/stock/biocept-inc/interest-paid https://stock.noler.com/us/stock/biocept-inc/interest-paid-net https://stock.noler.com/us/stock/biocept-inc/interest-payable-current https://stock.noler.com/us/stock/biocept-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/biocept-inc/inventory https://stock.noler.com/us/stock/biocept-inc/inventory-adjustments https://stock.noler.com/us/stock/biocept-inc/inventory-finished-goods https://stock.noler.com/us/stock/biocept-inc/inventory-gross https://stock.noler.com/us/stock/biocept-inc/inventory-raw-materials https://stock.noler.com/us/stock/biocept-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/biocept-inc/inventory-work-in-process https://stock.noler.com/us/stock/biocept-inc/inventory-write-down https://stock.noler.com/us/stock/biocept-inc/investing-cash-flow https://stock.noler.com/us/stock/biocept-inc/investment-sold-not-yet-purchased-sale-proceeds https://stock.noler.com/us/stock/biocept-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/biocept-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/biocept-inc/lease-and-rental-expense https://stock.noler.com/us/stock/biocept-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/biocept-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/biocept-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biocept-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/biocept-inc/liabilities-assumed https://stock.noler.com/us/stock/biocept-inc/liabilities-noncurrent https://stock.noler.com/us/stock/biocept-inc/line-of-credit https://stock.noler.com/us/stock/biocept-inc/line-of-credit-facility-commitment-fee-amount https://stock.noler.com/us/stock/biocept-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/biocept-inc/lines-of-credit-current https://stock.noler.com/us/stock/biocept-inc/long-term-line-of-credit https://stock.noler.com/us/stock/biocept-inc/long-term-notes-payable https://stock.noler.com/us/stock/biocept-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/biocept-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/biocept-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/biocept-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/biocept-inc/net-change-in-cash https://stock.noler.com/us/stock/biocept-inc/net-income https://stock.noler.com/us/stock/biocept-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/biocept-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/biocept-inc/notes-payable https://stock.noler.com/us/stock/biocept-inc/notes-payable-current https://stock.noler.com/us/stock/biocept-inc/number-of-reportable-segments https://stock.noler.com/us/stock/biocept-inc/operating-cash-flow https://stock.noler.com/us/stock/biocept-inc/operating-income https://stock.noler.com/us/stock/biocept-inc/operating-lease-assets https://stock.noler.com/us/stock/biocept-inc/operating-lease-cost https://stock.noler.com/us/stock/biocept-inc/operating-lease-liability https://stock.noler.com/us/stock/biocept-inc/operating-lease-liability-current https://stock.noler.com/us/stock/biocept-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/biocept-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/biocept-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/biocept-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/biocept-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/biocept-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/biocept-inc/other-income https://stock.noler.com/us/stock/biocept-inc/other-income-2 https://stock.noler.com/us/stock/biocept-inc/other-noncash-income https://stock.noler.com/us/stock/biocept-inc/other-noncash-income-expense https://stock.noler.com/us/stock/biocept-inc/other-noncurrent-assets https://stock.noler.com/us/stock/biocept-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/biocept-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/biocept-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/biocept-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/biocept-inc/paid-in-kind-interest https://stock.noler.com/us/stock/biocept-inc/patents-pending https://stock.noler.com/us/stock/biocept-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/biocept-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/biocept-inc/payments-to-acquire-equipment-on-lease https://stock.noler.com/us/stock/biocept-inc/payments-to-suppliers https://stock.noler.com/us/stock/biocept-inc/pension-and-other-postretirement-defined-benefit-plans-current-liabilities https://stock.noler.com/us/stock/biocept-inc/preferred-shares-facts https://stock.noler.com/us/stock/biocept-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/biocept-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/biocept-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biocept-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/biocept-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/biocept-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/biocept-inc/preferred-stock-value https://stock.noler.com/us/stock/biocept-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/biocept-inc/pretax-income https://stock.noler.com/us/stock/biocept-inc/prior-period-reclassification-adjustment https://stock.noler.com/us/stock/biocept-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/biocept-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/biocept-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/biocept-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/biocept-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/biocept-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/biocept-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/biocept-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/biocept-inc/profit-loss https://stock.noler.com/us/stock/biocept-inc/property-plant-and-equipment-additions https://stock.noler.com/us/stock/biocept-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/biocept-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/biocept-inc/property-plant-equipment https://stock.noler.com/us/stock/biocept-inc/public-float https://stock.noler.com/us/stock/biocept-inc/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/biocept-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/biocept-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/biocept-inc/repayments-of-other-debt https://stock.noler.com/us/stock/biocept-inc/research-and-development https://stock.noler.com/us/stock/biocept-inc/retained-earnings https://stock.noler.com/us/stock/biocept-inc/revenue https://stock.noler.com/us/stock/biocept-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/biocept-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/biocept-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/biocept-inc/sale-leaseback-transaction-net-proceeds-financing-activities https://stock.noler.com/us/stock/biocept-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/biocept-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/biocept-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/biocept-inc/sec-filings-10-k https://stock.noler.com/us/stock/biocept-inc/sec-filings-10-q https://stock.noler.com/us/stock/biocept-inc/sec-filings-25-nse https://stock.noler.com/us/stock/biocept-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/biocept-inc/sec-filings-8-k https://stock.noler.com/us/stock/biocept-inc/sec-filings-certnas https://stock.noler.com/us/stock/biocept-inc/sec-filings-ct-order https://stock.noler.com/us/stock/biocept-inc/sec-filings-def-14a https://stock.noler.com/us/stock/biocept-inc/sec-filings-defa14a https://stock.noler.com/us/stock/biocept-inc/sec-filings-defr14a https://stock.noler.com/us/stock/biocept-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/biocept-inc/sec-filings-regdex https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/biocept-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/biocept-inc/security-deposit https://stock.noler.com/us/stock/biocept-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/biocept-inc/share-price https://stock.noler.com/us/stock/biocept-inc/shareholders-equity https://stock.noler.com/us/stock/biocept-inc/shares-authorized https://stock.noler.com/us/stock/biocept-inc/shares-issued https://stock.noler.com/us/stock/biocept-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/biocept-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/biocept-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/biocept-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biocept-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/biocept-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/biocept-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/biocept-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/biocept-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/biocept-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/biocept-inc/stock-based-compensation https://stock.noler.com/us/stock/biocept-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/biocept-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/biocept-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/biocept-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/biocept-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/biocept-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/biocept-inc/stock-issued-shares-issued-shares-share-based-compensation-gross https://stock.noler.com/us/stock/biocept-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/biocept-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/biocept-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/biocept-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/biocept-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/biocept-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/biocept-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/biocept-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/biocept-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/biocept-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/biocept-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/biocept-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/biocept-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/biocept-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/biocept-inc/stock-split-ratio https://stock.noler.com/us/stock/biocept-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-tax-contingencies-state-and-local https://stock.noler.com/us/stock/biocept-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/biocept-inc/total-assets https://stock.noler.com/us/stock/biocept-inc/total-liabilities https://stock.noler.com/us/stock/biocept-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/biocept-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/biocept-inc/unbilled-receivables-current https://stock.noler.com/us/stock/biocept-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/biocept-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/biocept-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/biocept-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/biocept-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/biocept-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense